{"id":57475,"date":"2024-11-18T04:13:44","date_gmt":"2024-11-18T04:13:44","guid":{"rendered":"https:\/?p=57475"},"modified":"2024-11-18T04:13:44","modified_gmt":"2024-11-18T04:13:44","slug":"ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/","title":{"rendered":"AI Stock Analysis: Tyra Biosciences is emerging as a &#8220;Top Pick&#8221;"},"content":{"rendered":"<h2>Tyra Biosciences (TYRA)<\/h2>\n<p><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/TYRA#\">Tyra Biosciences<\/a> is emerging as a standout player in the biotechnology sector, with analysts and investors taking note of its strong growth potential and promising pipeline. One of the key drivers behind the stock&#8217;s positive momentum is the progress of its lead candidate, <strong>TYRA-300<\/strong>, which is being developed as a treatment for <strong>hypochondroplasia<\/strong>, a rare skeletal dysplasia caused by mutations in the FGFR3 gene. The compound has shown <strong>significant preclinical results<\/strong>, particularly in animal models, demonstrating notable skeletal improvements. This positions Tyra\u2019s drug favorably within the competitive landscape, especially when compared to similar drugs, like <strong>erdafitinib<\/strong> (marketed by <strong>Johnson &amp; Johnson<\/strong>), which has faced challenges with <strong>tolerability<\/strong> in patients.<\/p>\n<h3>Bank of America Upgrade<\/h3>\n<p>The <strong>upgrade from Bank of America (BofA) Securities <a href=\"https:\/\/www.stocktargetadvisor.com\/Analyst-Ranking\/Bank-of-America-Merrill-Lynch\">(Analyst Rank#17<\/a>)<\/strong> is a significant endorsement of Tyra&#8217;s potential. BofA raised its rating on the stock from <strong>Neutral to Buy<\/strong> and increased its <strong>price target<\/strong> from $22 to $31. This upgrade reflects optimism about the company\u2019s preclinical data and the future of TYRA-300, especially as the drug moves closer to clinical trials and potential commercialization. The analysts at BofA highlighted the <strong>strong preclinical results<\/strong>, which have positioned TYRA-300 as a promising candidate in a highly competitive market. Additionally, BofA analysts emphasized the favorable outlook for Tyra as the company gears up for <strong>upcoming clinical presentations<\/strong> that could provide further validation of the drug\u2019s efficacy and safety profile.<\/p>\n<p>Beyond TYRA-300, Tyra Biosciences is also gaining attention for its broader pipeline, which includes programs targeting other conditions such as <strong>metastatic urothelial carcinoma<\/strong> (a form of bladder cancer). <strong>Revenue growth projections<\/strong> for the company are robust, with analysts expecting Tyra to generate <strong>$175 million<\/strong> in adjusted sales for its urothelial carcinoma treatment by 2030. This growth forecast is grounded in Tyra&#8217;s ability to address unmet medical needs with differentiated therapies, giving it an edge over larger competitors.<\/p>\n<h3>Analyst Consensus<\/h3>\n<p>Investor sentiment towards Tyra has been overwhelmingly positive, as reflected in its <strong>89% stock price increase year-to-date<\/strong>, signaling strong confidence in the company\u2019s ability to deliver value. With an <strong>average analyst target price<\/strong> of <strong>$28.91<\/strong>, and a <strong>Strong Buy<\/strong> rating from analysts, the company has garnered widespread support<a href=\"https:\/\/www.stocktargetadvisor.com\/\">. <strong>Stock Target Advisor<\/strong> <\/a>has rated Tyra as <strong>Bullish<\/strong>, based on its strong track record and favorable signals, with <strong>five positive signals<\/strong> outweighing a single negative one.<\/p>\n<p>The upward momentum is not just driven by the company\u2019s preclinical results but also by its <strong>strategic positioning<\/strong> in the biotechnology market. With <strong>Tyra\u2019s pipeline<\/strong>, the company is setting itself up for potential commercial success, especially as it prepares to advance its clinical trials and navigate the path to regulatory approval. The positive outlook, combined with the strong backing from analysts, puts Tyra Biosciences in a strong position for long-term growth, as the company continues to execute on its promising development programs.<\/p>\n<h3>Outlook<\/h3>\n<p>In summary, Tyra Biosciences stands out as a <strong>high-potential biotech stock<\/strong>. It is well-positioned to benefit from the strong clinical data of its lead candidate, TYRA-300, and its broader pipeline targeting serious medical conditions. As investors and analysts anticipate further positive developments, Tyra&#8217;s stock performance, ratings, and projected revenue growth make it an attractive pick in the biotechnology space.<\/p>\n<p><a href=\"https:\/\/www.stocktargetadvisor.com\/discover\/end-of-summer-sale\/\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-54446 size-full\" src=\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6.png\" sizes=\"(max-width: 709px) 85vw, (max-width: 909px) 67vw, (max-width: 1362px) 62vw, 840px\" srcset=\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6.png 2000w, http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6-300x45.png 300w, http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6-1024x154.png 1024w, http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6-150x23.png 150w, http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6-768x115.png 768w, http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6-1536x230.png 1536w, http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/09\/STA-Promotion-Banner-6-1200x180.png 1200w\" alt=\"Promotion Banner\" width=\"2000\" height=\"300\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tyra Biosciences (TYRA) Tyra Biosciences is emerging as a standout player in the biotechnology sector, with analysts and investors taking note of its strong growth&#8230;<\/p>\n","protected":false},"author":3,"featured_media":57478,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-57475","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AI Stock Analysis: Tyra Biosciences is emerging as a &quot;Top Pick&quot; | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AI Stock Analysis: Tyra Biosciences is emerging as a &quot;Top Pick&quot;\" \/>\n<meta property=\"og:description\" content=\"Tyra Biosciences (TYRA) Tyra Biosciences is emerging as a standout player in the biotechnology sector, with analysts and investors taking note of its strong growth...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-18T04:13:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/11\/Tyra.png\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"AI Stock Analysis: Tyra Biosciences is emerging as a &#8220;Top Pick&#8221;\",\"datePublished\":\"2024-11-18T04:13:44+00:00\",\"dateModified\":\"2024-11-18T04:13:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/\"},\"wordCount\":537,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/\",\"name\":\"AI Stock Analysis: Tyra Biosciences is emerging as a \\\"Top Pick\\\" | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2024-11-18T04:13:44+00:00\",\"dateModified\":\"2024-11-18T04:13:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AI Stock Analysis: Tyra Biosciences is emerging as a &#8220;Top Pick&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AI Stock Analysis: Tyra Biosciences is emerging as a \"Top Pick\" | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/","og_locale":"en_US","og_type":"article","og_title":"AI Stock Analysis: Tyra Biosciences is emerging as a \"Top Pick\"","og_description":"Tyra Biosciences (TYRA) Tyra Biosciences is emerging as a standout player in the biotechnology sector, with analysts and investors taking note of its strong growth...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2024-11-18T04:13:44+00:00","og_image":[{"width":700,"height":280,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/11\/Tyra.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"AI Stock Analysis: Tyra Biosciences is emerging as a &#8220;Top Pick&#8221;","datePublished":"2024-11-18T04:13:44+00:00","dateModified":"2024-11-18T04:13:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/"},"wordCount":537,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/","name":"AI Stock Analysis: Tyra Biosciences is emerging as a \"Top Pick\" | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2024-11-18T04:13:44+00:00","dateModified":"2024-11-18T04:13:44+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/ai-stock-analysis-tyra-biosciences-is-emerging-as-a-top-pick\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"AI Stock Analysis: Tyra Biosciences is emerging as a &#8220;Top Pick&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/57475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=57475"}],"version-history":[{"count":4,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/57475\/revisions"}],"predecessor-version":[{"id":57482,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/57475\/revisions\/57482"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/57478"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=57475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=57475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=57475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}